Company Overview
C. S. T. Pharma Limited is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Wednesday 09 May 2001, so this is a well established company. C. S. T. Pharma Limited has been in business for 24 years and 10 months. The accounts status is full and the accounts are next due on Saturday 31 January 2026.
Registered Address

Unit 5-7 Tintagel Way, Westgate Park Industrial Estate Aldridge, Walsall, WS9 8ER
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameC. S. T. PHARMA LIMITED
Company Number04212740
Registered Office AddressUnit 5-7 Tintagel Way
 Westgate Park Industrial Estate Aldridge
 WS9 8ER
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date09/05/2001
Accounting Reference Date Day30
Accounting Reference Date Month4
Accounts Next Due Date31/01/2027
Accounts Last Made Up Date30/04/2025
Accounts Account CategoryFULL
Returns Next Due Date06/06/2017
Returns Last Made Up Date09/05/2016
Directors & Members
Show Resigned
Carl Falzon - Director
(British, 49 years old, born June 1977)
Appointed 28 August 2018
 Active
Caroline Poynter - Director
(British, 62 years old, born May 1964)
Appointed 28 August 2018
 Active
Ian Pritchard - Director
(British, 57 years old, born December 1969)
Appointed 05 August 2019
 Active
Jason Yates - Director
(British, 53 years old, born June 1973)
Appointed 28 August 2018
 Active
Secretaries
Show Resigned
Other Company Directorships
Carl Falzon
ACRE AESTHETICS LIMITED
ACRE MEDICAL LIMITED
ACRE PHARMA LIMITED
ACRE PHARMACEUTICALS LIMITED
BLACK CAT HOUSING LTD
C.S.T. PHARMA GROUP HOLDINGS LIMITED
CST HOLDINGS (UK) LIMITED
CST INTERNATIONAL HOLDINGS LIMITED
MPT PHARMA LIMITED
THE BRITISH ASSOCIATION OF EUROPEAN PHARMACEUTICAL DISTRIBUTORS
UK PHARMA DIRECT LIMITED
UTH AESTHETICS LIMITED
Caroline Poynter
ACRE PHARMACEUTICALS LIMITED
C.S.T. PHARMA GROUP HOLDINGS LIMITED
CST CLASSICS LIMITED
CST ESTATES LIMITED
CST HOLDINGS (UK) LIMITED
CST INTERNATIONAL HOLDINGS LIMITED
DANUM RECRUITMENT AND TRAINING LIMITED
DANUM SOLUTIONS LIMITED
DMG WHOLESALE LIMITED
MPT PHARMA LIMITED
POWERPLACE LTD
Ian Pritchard
ACER PHARMA LIMITED
ACRE AESTHETICS HOLDINGS LIMITED
ACRE AESTHETICS LIMITED
ACRE MEDICAL LIMITED
ACRE PHARMA LIMITED
ACRE PHARMACEUTICALS LIMITED
ARTHROUS LIMITED
B.G. ELECTRICAL HOLDINGS LIMITED
BG ELECTRICAL LIMITED
C.S.T. PHARMA GROUP HOLDINGS LIMITED
COSMEDIC PHARMACY LIMITED
CST ESTATES LIMITED
CST HOLDINGS (UK) LIMITED
CST INTERNATIONAL HOLDINGS LIMITED
CST PHARMA HOLDINGS LIMITED
CURAGENIX LIFE SCIENCES LIMITED
DMG WHOLESALE LIMITED
KINGFISHER LIGHTING LIMITED
LUCECO HOLDINGS LIMITED
LUCECO LIGHTING LIMITED
LUCECO PLC
LUCECO UK LIMITED
MASTERPLUG HOLDINGS LIMITED
MASTERPLUG LIMITED
MENDOO LIMITED
MPT PHARMA LIMITED
NEXUS CIRRUS LIMITED
PRESCRIPTIFY LIMITED
PRITCHARD ACCOUNTANCY SERVICES LIMITED
PRITCHARD ACCOUNTANCY SOLUTIONS LIMITED
SYNERTECH LTD
UK PHARMA DIRECT LIMITED
UTH AESTHETICS LIMITED
Jason Yates
ACER PHARMA LIMITED
ACRE AESTHETICS LIMITED
ACRE MEDICAL LIMITED
ACRE PHARMACEUTICALS LIMITED
ARTHROUS LIMITED
C.S.T. PHARMA GROUP HOLDINGS LIMITED
CST ESTATES LIMITED
CST INTERNATIONAL HOLDINGS LIMITED
CURAGENIX LIFE SCIENCES LIMITED
IBBQ UK LTD
JLY CONSULTING LIMITED
MPT PHARMA LIMITED
PRESCRIPTIFY LIMITED
SHADOW INTERIORS LTD
SYNERTECH LTD
UK PHARMA DIRECT LIMITED
UTH AESTHETICS LIMITED
Balance Sheet Unlock full report
Accounts Date 30-Apr-2025 30-Apr-2015 30-Apr-2014
Balance Sheet
Fixed Assets 1,401,000 1,401,000 3,873,000
Current Assets 30,741,000 30,741,000 22,934,000
Creditors Due Within One Year 21,131,000 21,131,000 13,739,000
Working Cap 9,610,000 9,610,000 9,195,000
Total Assets Less Current Liabilities 11,011,000 11,011,000 13,068,000
Long-term Liabilities 4,014,000 4,014,000 4,003,000
Net Assets 6,997,000 6,997,000 9,065,000
Share Capital & Reserves
Share Cap 0 0 0
Profit & Loss Reserves 6,997,000 6,997,000 9,065,000
Other Reserves 0 0 0
Shareholders Funds 6,997,000 6,997,000 9,065,000
Common Size Financial Analysis Unlock full report
Accounts Date 30-Apr-2025 30-Apr-2015 30-Apr-2014
Tangible Fixed Assets - - -
Fixed Assets 4.4% 4.4% 14.4%
Stocks Inventory 34.6% 34.6% 38.0%
Debtors 50.8% 50.8% 39.9%
Cash Bank In Hand 2.3% 2.3% 0.2%
Current Assets 95.6% 95.6% 85.6%
Creditors Due Within One Year 65.7% 65.7% 51.3%
Net Current Assets Liabilities 29.9% 29.9% 34.3%
Creditors Due After One Year 12.5% 12.5% 14.9%
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability 21.8% 21.8% 33.8%
Called Up Share Capital 0.0% 0.0% 0.0%
Share Capital Allotted Called Up Paid 0.0% 0.0% 0.0%
Profit Loss Account Reserve 21.8% 21.8% 33.8%
Shareholder Funds 21.8% 21.8% 33.8%
Capital Employed - - -
Total Assets Less Current Liabilities 34.3% 34.3% 48.7%
Financial Ratio Analysis Unlock full report
Accounts Date 30-Apr-2025 30-Apr-2015 30-Apr-2014
Liquidity Ratio 1.5 1.5 1.7
Solvency Ratio 1.3 1.3 1.5
Reserves to Assets 0.2 0.2 0.3
Secured Creditors Unlock full report
Mortgages Charges 12
Mortgages Outstanding 6
Mortgages Part Satisfied 0
Mortgages Satisfied 6
Assets and Debt Analysis Unlock full report
Accounts Date 30-Apr-2025 30-Apr-2015 30-Apr-2014
Assets 32,142,000 32,142,000 26,807,000
Debt 25,145,000 25,145,000 17,742,000
Net Assets/Debt 6,997,000 6,997,000 9,065,000

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. The amount of net assets suggests sufficient cover for total debts and obligations for the size of the company inferred by the balance sheet.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. The amount of net assets suggests sufficient cover for total debts and obligations for the size of the company inferred by the balance sheet.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. The amount of net assets suggests sufficient cover for total debts and obligations for the size of the company inferred by the balance sheet.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around WS9 8ER
BERNSTEIN LTD
UNIT 1 TINTAGEL WAY, WESTGATE ALDRIDGE, WALSALL, WEST MIDLANDS, WS9 8ER
ACRE PHARMA LIMITED
Unit 5-7 Tintagel Way, Aldridge, Walsall, WS9 8ER
MPT PHARMA LIMITED
UNIT 5-7 TINTAGEL WAY, WESTGATE PARK INDUSTRIAL ESTATE ALDRIDGE, WALSALL, WS9 8ER
SECOND CITY LIFT TRUCK LIMITED
UNIT 8 WESTGATE PARK INDUSTRIAL ESTATE, TINTAGEL WAY, ALDRIDGE, WEST MIDLANDS, WS9 8ER
DMG WHOLESALE LIMITED
Unit 5-7 Tintagel Way, Aldridge, Walsall, West Midlands, WS9 8ER
CST ESTATES LIMITED
Westgate Park, Units 5-7, Tintagel Way, Aldridge, Walsall, WS9 8ER
CST CLASSICS LIMITED
Westgate Park, Units 5-7, Tintagel Way, Aldridge, Walsall, WS9 8ER
CST HOLDINGS (UK) LIMITED
WESTGATE PARK, UNITS 5-7 TINTAGEL WAY, ALDRIDGE, WALSALL, WS9 8ER
B & J DISTRIBUTION LIMITED
UNIT 3 TINTAGEL WAY, ALDRIDGE, WALSALL, WEST MIDLANDS, WS9 8ER
JOFSON NORTH LTD
UNIT 8 WESTGATE PARK INDUSTRIAL ESTATE, TINTAGEL WAY, ALDRIDGE, WEST MIDLANDS, WS9 8ER
Document Filings
Confirmation statement made on 9 May 2025 with updates
Cessation of Cst Holdings (Uk) Limited as a person with significant control on 1 April 2025
Notification of Cst Pharma Group Holdings as a person with significant control on 1 April 2025
Confirmation statement made on 9 May 2024 with no updates
Registration of charge 042127400012, created on 27 March 2024
Confirmation statement made on 9 May 2023 with no updates
Termination of appointment of Michelle Grenan as a director on 30 January 2023
Confirmation statement made on 9 May 2022 with no updates
Satisfaction of charge 4 in full
Satisfaction of charge 042127400006 in full
Satisfaction of charge 5 in full
Registration of charge 042127400007, created on 30 July 2021
Registration of charge 042127400008, created on 30 July 2021
Registration of charge 042127400010, created on 30 July 2021
Registration of charge 042127400009, created on 30 July 2021
Registration of charge 042127400011, created on 30 July 2021
Confirmation statement made on 9 May 2021 with no updates
Confirmation statement made on 9 May 2020 with no updates
Appointment of Dr Michelle Grenan as a director on 1 May 2020
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free